BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28176790)

  • 1. Architectural and functional alterations of the small intestinal mucosa in classical Whipple's disease.
    Epple HJ; Friebel J; Moos V; Troeger H; Krug SM; Allers K; Schinnerling K; Fromm A; Siegmund B; Fromm M; Schulzke JD; Schneider T
    Mucosal Immunol; 2017 Nov; 10(6):1542-1552. PubMed ID: 28176790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal barrier dysfunction mediates Whipple's disease immune reconstitution inflammatory syndrome (IRIS).
    Friebel J; Schinnerling K; Geelhaar-Karsch A; Allers K; Schneider T; Moos V
    Immun Inflamm Dis; 2022 May; 10(5):e622. PubMed ID: 35478447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific and nonspecific B-cell function in the small intestines of patients with Whipple's disease.
    Geelhaar A; Moos V; Schinnerling K; Allers K; Loddenkemper C; Fenollar F; LaScola B; Raoult D; Schneider T
    Infect Immun; 2010 Nov; 78(11):4589-92. PubMed ID: 20696822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T cells in patients with Whipple's disease.
    Schinnerling K; Moos V; Geelhaar A; Allers K; Loddenkemper C; Friebel J; Conrad K; Kühl AA; Erben U; Schneider T
    J Immunol; 2011 Oct; 187(8):4061-7. PubMed ID: 21918190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial barrier dysfunction in lymphocytic colitis through cytokine-dependent internalization of claudin-5 and -8.
    Barmeyer C; Erko I; Awad K; Fromm A; Bojarski C; Meissner S; Loddenkemper C; Kerick M; Siegmund B; Fromm M; Schweiger MR; Schulzke JD
    J Gastroenterol; 2017 Oct; 52(10):1090-1100. PubMed ID: 28138755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients.
    Epple HJ; Schneider T; Troeger H; Kunkel D; Allers K; Moos V; Amasheh M; Loddenkemper C; Fromm M; Zeitz M; Schulzke JD
    Gut; 2009 Feb; 58(2):220-7. PubMed ID: 18936106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholera toxin perturbs the paracellular barrier in the small intestinal epithelium of rats by affecting claudin-2 and tricellulin.
    Markov AG; Vishnevskaya ON; Okorokova LS; Fedorova AA; Kruglova NM; Rybalchenko OV; Aschenbach JR; Amasheh S
    Pflugers Arch; 2019 Sep; 471(9):1183-1189. PubMed ID: 31222489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired immune functions of monocytes and macrophages in Whipple's disease.
    Moos V; Schmidt C; Geelhaar A; Kunkel D; Allers K; Schinnerling K; Loddenkemper C; Fenollar F; Moter A; Raoult D; Ignatius R; Schneider T
    Gastroenterology; 2010 Jan; 138(1):210-20. PubMed ID: 19664628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal epithelial claudins: expression and regulation in homeostasis and inflammation.
    Garcia-Hernandez V; Quiros M; Nusrat A
    Ann N Y Acad Sci; 2017 Jun; 1397(1):66-79. PubMed ID: 28493289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral T-Cell Reactivity to Heat Shock Protein 70 and Its Cofactor GrpE from Tropheryma whipplei Is Reduced in Patients with Classical Whipple's Disease.
    Trotta L; Weigt K; Schinnerling K; Geelhaar-Karsch A; Oelkers G; Biagi F; Corazza GR; Allers K; Schneider T; Erben U; Moos V
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28559404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple's disease.
    Moos V; Kunkel D; Marth T; Feurle GE; LaScola B; Ignatius R; Zeitz M; Schneider T
    J Immunol; 2006 Aug; 177(3):2015-22. PubMed ID: 16849516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tight junction, selective permeability, and related diseases.
    Krug SM; Schulzke JD; Fromm M
    Semin Cell Dev Biol; 2014 Dec; 36():166-76. PubMed ID: 25220018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic Giardia lamblia infection on epithelial transport and barrier function in human duodenum.
    Troeger H; Epple HJ; Schneider T; Wahnschaffe U; Ullrich R; Burchard GD; Jelinek T; Zeitz M; Fromm M; Schulzke JD
    Gut; 2007 Mar; 56(3):328-35. PubMed ID: 16935925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders.
    Fiorentino M; Sapone A; Senger S; Camhi SS; Kadzielski SM; Buie TM; Kelly DL; Cascella N; Fasano A
    Mol Autism; 2016; 7():49. PubMed ID: 27957319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity.
    Weber CR; Raleigh DR; Su L; Shen L; Sullivan EA; Wang Y; Turner JR
    J Biol Chem; 2010 Apr; 285(16):12037-46. PubMed ID: 20177070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whipple's disease: a histological, immunocytochemical and electronmicroscopic study of the immune response in the small intestinal mucosa.
    Ectors N; Geboes K; De Vos R; Heidbuchel H; Rutgeerts P; Desmet V; Vantrappen G
    Histopathology; 1992 Jul; 21(1):1-12. PubMed ID: 1378814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cingulin is dispensable for epithelial barrier function and tight junction structure, and plays a role in the control of claudin-2 expression and response to duodenal mucosa injury.
    Guillemot L; Schneider Y; Brun P; Castagliuolo I; Pizzuti D; Martines D; Jond L; Bongiovanni M; Citi S
    J Cell Sci; 2012 Nov; 125(Pt 21):5005-14. PubMed ID: 22946046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In tight junctions, claudins regulate the interactions between occludin, tricellulin and marvelD3, which, inversely, modulate claudin oligomerization.
    Cording J; Berg J; Käding N; Bellmann C; Tscheik C; Westphal JK; Milatz S; Günzel D; Wolburg H; Piontek J; Huber O; Blasig IE
    J Cell Sci; 2013 Jan; 126(Pt 2):554-64. PubMed ID: 23203797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopathology of immune reconstitution inflammatory syndrome in Whipple's disease.
    Moos V; Feurle GE; Schinnerling K; Geelhaar A; Friebel J; Allers K; Moter A; Kikhney J; Loddenkemper C; Kühl AA; Erben U; Fenollar F; Raoult D; Schneider T
    J Immunol; 2013 Mar; 190(5):2354-61. PubMed ID: 23365082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Necrosis Factor Inhibitors Exacerbate Whipple's Disease by Reprogramming Macrophage and Inducing Apoptosis.
    Boumaza A; Mezouar S; Bardou M; Raoult D; Mège JL; Desnues B
    Front Immunol; 2021; 12():667357. PubMed ID: 34093562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.